The reliable production of large amounts of stable, high-quality proteins is a major challenge facing pharmaceutical protein biochemists, necessary for fulfilling demands from structural biology, for high-throughput screening, and for assay purposes throughout early discovery. One strategy for bypassing purification challenges in problematic systems is to engineer multiple forms of a particular protein to optimize expression, purification, and stability, often resulting in a nonphysiological subdomain. An alternative strategy is to alter process conditions to maximize wild-type construct stability, based on a specific protein stability profile (PSP). ThermoFluor ® , a miniaturized 384-well thermal stability assay, has been implemented as a means of monitoring solution-dependent changes in protein stability, complementing the protein engineering and purification processes. A systematic analysis of pH, buffer or salt identity and concentration, biological metals, surfactants, and common excipients in terms of an effect on protein stability rapidly identifies conditions that might be used (or avoided) during protein production. Two PSPs are presented for the kinase catalytic domains of Akt-3 and cFMS, in which information derived from a ThermoFluor ® PSP led to an altered purification strategy, improving the yield and quality of the protein using the primary sequences of the catalytic domains. (Journal of Biomolecular Screening 2007:418-428) 
INTRODUCTION

A
GGREGATION IS A COMMON OBSTACLE both in protein biochemistry and in protein therapeutics. For more than 50 years, scientists have been struggling to understand the relationship between reversible protein denaturation and competing irreversible processes.
1,2 Protein aggregation is highly correlated with certain diseases, such as Alzheimer's, Parkinson's, and Huntington's, and prion-mediated amyloidogenic diseases. 3, 4 In addition, aggregation is an impediment toward formulation of biologicals during development 5, 6 and in protein overexpression and purification during discovery.
Protein stability measurements, and finding means of increasing stability, have similarly spurred widespread interest in the scientific community. A thermodynamic description of protein stability requires quantitation of the equilibrium between folded and unfolded states, either by denaturant-induced 7, 8 or thermally induced unfolding. 9, 10 In addition to denaturants and temperature, variables known to influence protein stability include pH and proton linkage, 8, 11 salt type and concentration, 12 cosolvents and osmolytes, 12, 13 preservatives, 5, 14 and surfactants. 15 Variations in any of these can alter ligand binding and enzymatic activity, may influence unfolding and aggregation, 5, 8 and can drive crystallization in structural biology programs. 12 Solution effects on protein stability are generally discovered through serial observations. A common approach to augmenting protein stability is to engineer constructs, potentially also improving expression, purification, or activity. Alternatively, investigation of the protein stability landscape as a function of its environment may be used to overcome problems of stability without the need to vary the primary protein sequence through mutagenesis. A thorough investigation of intrinsic protein stability in the context of environmental factors may achieve the same improvements in protein stability without the need for protein engineering. Over time, a detailed picture of a protein's unique stability may be fully explored.
The unique challenges associated with understanding in detail each new pharmacologically important protein are most efficiently addressed by a systematic approach. ThermoFluor provides a high-throughput measure of stability perturbations due to effects of ligand binding and solution conditions. 16, 17 .
ThermoFluor
® was originally developed for high-throughput screening (HTS), yet it has other applications. Practically speaking, assay development in advance of ThermoFluor ® -based HTS is a function of maximizing the fluorescent signal corresponding to protein unfolding, minimizing the concentration of protein per well, and simultaneously maximizing protein longevity and plate reproducibility over the course of robotic manipulation (up to 24 h). In addition, applications of ThermoFluor ® protein stability profiling (PSP) have had a surprising impact on protein production, notably for the 2 example proteins presented here: the kinase catalytic domains from Akt-3 and cFMS.
The demand for finding therapeutic agents active against kinases is significant. 18, 19 One example is the c-fms protooncogene, a receptor protein tyrosine kinase, which is involved in regulating differentiation and maturation of most macrophages. 20, 21 A 2nd example is the soluble Ser/Thr kinase Akt-3, a member of the AGC kinase family and a critical component of intracellular signaling controlling the response to insulin and inflammatory agents. 22 Specifically, Akt-3 is overexpressed and amplified in different tumors 22, 23 while not being highly expressed in liver or skeletal muscle (where Akt-1 and Akt-2 expression is relevant), suggesting Akt-3 may be a promising target for the discovery of novel chemotherapeutics that do not interfere with insulin signaling. 22 Eukaryotic protein kinases are composed of a 250-aminoacid catalytic domain, under control of 1 or more regulatory domains. 24 During initial characterization of cFMS and Akt-3 in preparation for separate HTS campaigns, progress in both systems suffered from aggregation during protein purification. In lieu of a protein engineering effort, we pursued a systematic approach to generate a PSP using ThermoFluor ® technology. From each, a different set of solution conditions was identified as being stabilizing and/or destabilizing to the core catalytic domains. Following changes to protein purification procedures, the aggregation problem was alleviated; purification quality and yield was increased for both systems.
MATERIALS AND METHODS
ANS (1-anilino-8-naphthanlenesulfonate) was from Molecular Probes (Carlsbad, CA); buffers, salts, and additives were from Sigma-Aldrich (St Louis, MO). PCR plates with 384 wells (Abgene, Epsom, UK) were used for ThermoFluor ® experiments. Thrombin was from Enzyme Research Labs (South Bend, IN).
Protein expression and purification
cFMS purification. Cloning of c-fms and protein overexpression is described elsewhere. 25 Briefly, the cFMS catalytic domain was expressed in Sf9 cells; cell pellets were thawed in lysis/column wash buffer (25 mM HEPES pH 7.5, 400 mM NaCl, 10% glycerol, 1 mM glutathione, 20 mM imidazole, 0.1mM PMSF, (1×) complete EDTA-free protease inhibitors [Roche, Basel, Switzerland]), followed by dounce homogenization and clarification by centrifugation (40,000g, 40 min). Initially, cFMS was batch purified on an Ni-NTA Superflow resin (Qiagen, Venlo, the Netherlands) at 4 °C and was eluted using a linear gradient up to 100 mM imidazole. Following ThermoFluor ® -based PSP (described below), alterations were made to the above cFMS purification protocol: TALON metal affinity resin (Clontech Laboratories, Inc, Mountain View, CA) was substituted for Ni-NTA resin, the column buffer was changed to 25 mM KH 2 PO 4 , in lieu of HEPES buffer (pH unchanged at 7.5), and glycerol was reduced from 10% to 5%. The column gradient was also modified using a lower initial imidazole concentration (reduced from 20 mM to 5 mM) and eluting with a gradient to 200 mM imidazole.
Akt-3 purification.
A description of Akt-3 cloning and overexpression is described elsewhere. 22 Cell pellets were resuspended in cell lysis buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 2 mM DTT, (1×) Roche protease inhibitor tablets, lysed (Avestin Emulsiflex-C5), and clarified by centrifugation (56,000g, 50 min) to remove insoluble material. The Akt-3 was batch purified on Glutathione Sepharose 4 Fast Flow resin (Pharmacia, New York, NY) overnight at 4° C on an AKTA Explorer System (GE Healthcare, Piscataway, NJ). The protein-bound resin was washed with cell lysis buffer and then with thrombin cleavage buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, and 1 mM DTT). The GST-Akt-3-bound resin was recovered, followed by batch thrombin cleavage (∼9 NIH units thrombin/mg fusion protein, 25 °C ∼2 h). Thrombin was removed by batch binding to benzamidine sepharose. Following ThermoFluor ® -based PSP (described below), alterations were made: the thrombin cleavage buffer was changed (50 mM PIPES pH 6.5, 100 mM NaCl, 10% glycerol), and the fusion protein cleavage conditions were reoptimized for ∼18 h.
The oligomeric state of both Akt-3 and cFMS was assessed using a Superdex 200 column pre-equilibrated in the appropriate buffer; elution was monitored at 280 nm. Standards were 200, 150, 66, 29, and 12 kD (Sigma).
Assembly of 384-condition plates
Three 384-well plates were developed, each designed to test a different set of common biochemical conditions: a pH/salt plate, a crystallography buffer plate, and an excipient/additive plate. All conditions appear in left-right duplicates (layouts are supplied as supplemental materials), prepared as (2×) stock plates. Each solution was individually pH adjusted to the designated pH (pH 7.0 for the excipient plate). Journal of Biomolecular Screening 12(3); 2007 ThermoFluor ® ® assay plate assembly ThermoFluor ® assays are generally ≤ 4 µL, ∼1 to 5 µM protein (generally 20-100 µg/mL). For each experiment, 2 µL of the relevant (2×) stock solutions were dispensed into assay plates, followed by addition of 2 µL protein solution, containing both (2×) protein and ANS in a dilute solution (eg, 5 mM PIPES, pH 7.5, 10 mM NaCl). One microliter of silicone oil overlay prevents loss from evaporation during sample heating. Assay plates were centrifuged at ∼1000g, ∼1 min (Eppendorf plate centrifuge). For both Akt-3 and cFMS, 50 µM ANS was included in the final protein solution, and the protein concentration was 0.1 mg/mL.
Assay plates were analyzed using ThermoFluor ® instrumentation 17 manufactured within Johnson & Johnson Pharmaceutical Research and Development, LLC. ThermoFluor ® instruments were programmed to ramp temperature from 25 °C to 85 °C at ∼1 °C/min; fluorescence was measured at 1 °C increments, imaging plate fluorescence via CCD camera. Fluorescence is generated by Hg-Xe arc lamp (Hamamatsu, Bridgewater, NJ), filtered through custom interference excitation (385 ± 20 nm) and emission (500 ± 25 nm) filters (Omega Optical, Battleboro, VT). The primary data (relative fluorescence intensity v. temperature) are fit to standard equations describing protein thermal stability as previously described, 16 giving 6 fit parameters: T m , the midpoint in the transition between native and nonnative protein; ∆ U H (T) , the van't Hoff enthalpy for reversibly unfolding reactions; and linear baselines for native and unfolded protein (referenced to the protein T m ). The precision in T m determination is generally ±0.1 °C to 0.2 °C, although it is somewhat dependent on the type and concentration of both protein and dye.
RESULTS
Protein Stability Profiling
ThermoFluor
® is a protein stability assay that uses an environmentally sensitive dye to monitor the amount of unfolded protein in solution as a function of temperature. 16, 17 As the temperature increases, the fraction of nonnative protein increases, producing a cooperative unfolding transition. The midpoint temperature, T m , of such a transition is defined as the temperature at which the concentration of native and nonnative protein is equivalent ([N] = [U]), and the equilibrium between native and nonnative species is K U = [U]/[N] = 1; thus, the free energy is zero, as ∆ U G (Tm) = -nRT ln K U . Under conditions in which unfolding is reversible, fits also provide information on the enthalpy of unfolding, ∆ U H (Tm) , and heat capacity of unfolding, ∆ U C p , providing a complete description of the temperature dependence of protein stability. 26 Owing to the simple relationship between T m and ∆ U G(T) for the free energy of protein unfolding, the effects of solution composition on T m can be directly related to changes in protein stability.
Here, effects of solution conditions on protein stability are measured using a matrix-based approach in a of 384-well characterization plates (For supplemental materials, go to http:// jbx.sagepub.com/cgi/content/full/12/3/418/DC1.) containing variable buffer composition by well within prearranged plates. These are combined with cFMS or Akt-3 with ANS into assay plates and then are subjected to ThermoFluor ® protein unfolding analysis. Representative normalized ThermoFluor ® -derived thermal denaturation data depict a subset of results from plate-based exploration of cFMS and Akt-3 stability profiling ( Fig. 1, Table 1 ). For graphical comparison of ∆T m , relative fluorescence intensity is normalized to the fitted baselines for native and denatured states for each unfolding transition to express fraction unfolded protein versus temperature. 16, 17 The T m of cFMS is increased +2.4 °C from pH 6.0 to 7.0, suggesting a link between stability and a pH-dependent protonation event on the protein (Fig. 1A) . Stability is also dependent on ionic strength, based on an observed increase in stability (∆T m = +2.7 °C) when [NaCl] is raised from 100 to 500 mM at pH 7.0. In contrast to cFMS, Akt-3 stability (Fig. 1B) is decreased (∆T m = -1.8 °C) in response to elevating solution pH from 6.0 to 7.0, whereas changing NaCl has little effect on stability.
The effect of NaPO 4 on cFMS and Akt-3 stability is evaluated at 2 concentrations of the buffer (Fig. 1C, D) . For cFMS (Fig.  1C) , phosphate induces an increase in stability, ∆T m = +0.8 °C from 25 mM to 100 mM NaPO 4 , an effect above an ionic strength effect alone. Conversely, Akt-3 thermal stability is diminished, ∆T m = -1.4 °C, in response to increasing phosphate concentration (Fig. 1D) ; there is an additional effect of phosphate concentration on the apparent unfolding enthalpy (Table 1) , decreasing from 81 kcal/mol to 64 kcal/mol in 100 mM and 25 mM NaPO 4 , respectively. This effect is visually confirmed by a change in the slope of the unfolding transition around the fitted T m of Akt-3.
Relatively minor changes in solution conditions can have a sizeable effect on protein stability. An approach to address many variables simultaneously is a matrix of conditions in which individual variables might be systematically varied, testing stability versus a large set of conditions in parallel. Three arrays of conditions (supplemental materials) were assayed for cFMS and Akt-3. The 1st explores pH, buffer identity, concentration, salt concentration, and the presence of the common biological metal magnesium. The 2nd assays common biochemical excipients. The 3rd assesses protein stability in buffers commonly used in crystallography. These matrices of conditions are routinely examined for systematic effects on T m , on protein (or dye) fluorescence, and on protein unfolding enthalpy, ∆ U, H app (Tm) . Stability surfaces are readily generated from matrix-based protein characterization studies; the effect of pH and NaCl on cFMS ( Fig. 2A) or Akt-3 ( Fig. 2B) thermal stability are generated from a 9 × 7 subset of conditions, composed of 63 individual measurements of protein unfolding from within the ∼1000-well characterization profile. These stability surfaces are useful in graphically representing global differences across protein samples. It is apparent that cFMS and Akt-3 differ in the dependence of stability on pH and ionic strength (stabilizing for cFMS and destabilizing for Akt-3).
Significantly more information can be discerned by comparing individual combinations of buffer effects, such as the effect of systematic variation of pH and salt on the stability of cFMS and Akt-3 (Fig. 3) . The pH effect identified for cFMS stability in Figure 1A is expanded in Figure 3A , showing fluctuations in The maximum in cFMS stability is achieved at a pH greater than 7.0, regardless of NaCl and MgCl 2 concentration. NaCl at 100 mM causes a uniform, pH-independent increase in stability, ∆T m ∼ +2°C, consistent with a general stabilizing effect of NaCl. 8 MgCl 2 has limited effect on cFMS stability under any of these conditions. Figure 3B demonstrates a significantly different pH effect on Akt-3 as compared to cFMS, indicating a pH of maximum stability between 6 and 6.5. For Akt-3, NaCl and/or MgCl 2 caused a uniformly modest pH-independent decrease in stability.
The effect of NaCl concentration on the stability of both proteins was further defined by comparing stability over a gradient of NaCl, using different buffers within the condition profiling plates. Comparing 4 different buffers at pH 7.0, cFMS is stabilized (∆T m ∼ 4 °C) as a function of increasing [NaCl] concentration (Fig. 3C) . The same conditions show a moderate destabilization of Akt-3 as a function of ionic strength (Fig. 3D) . A further comparison of 4 different buffers shows a buffer effect on cFMS stability when compared across any individual [NaCl]; cFMS stability is highest in phosphate buffer, followed by PIPES and then HEPES and MOPS. The opposite is seen to be true for Akt-3. From these data alone, it is difficult to discern a mechanism for this rank order, although the trend is consistent across varying concentrations of buffer components. Figures 3C and 3D also define how protein stability is affected by 100 mM of each buffer at no added NaCl (filled symbols), relative to T m values measured in 25 mM buffer and varying [NaCl] (open symbols). These data are consistent with a buffer-specific stabilizing effect of phosphate on cFMS relative to a general ionic strength effect of HEPES and MOPS (note T m increases from 51 °C to 55 °C, resulting from increased phosphate from 25 to 100 mM). A different trend is observed for Akt-3, in which high buffer concentration destabilizes protein by an amount equivalent to the ionic strength change. These same pH and salt effects are mirrored in other combinations of primary solution conditions comparing cFMS and Akt-3 stability (not shown).
A more extensive profile of buffer effect on protein stability (at pH 7.5) was undertaken using a set of buffers commonly used in crystallography, tested at either 50 mM or 100 mM, as a function of varying pH. Selected data collected using 9 buffers, each at pH 7.5, is shown for cFMS and Akt-3 (Fig. 4A, B, respectively) . cFMS has the highest stability in phosphate, citrate, and succinate buffers, relative to a water reference T m ; buffers that show significant destabilization for cFMS include HEPES, imidazole-maleate, and bis-Tris-propane but, interestingly, not Tris. These data are consistent with that in Figure 3C and suggest that not only phosphate but also citrate and perhaps succinate may bind to the protein. It should be noted that many proteins are stabilized by citrate and succinate buffers (Tara M. Mezzasalma, unpublished data), either because of the high ionic strength accompanying these buffers or because of specific binding to the protein. These components of the citric acid cycle are at moderate concentrations in vivo and may have a relevant effect on protein stability and potentially enzyme activity. Akt-3 exhibits a different stability pattern against these same 9 buffers (Fig. 4B) ; bis-Trispropane was destabilizing and HEPES was slightly stabilizing, whereas all other buffers had no statistically significant effect on stability. Notably, the citrate-and succinate-mediated stabilization observed for cFMS is absent for Akt-3, highlighting the protein-specific nature of PSP.
An excipient/additive plate is also assayed (at 2 concentrations per component); the general composition includes variations in salts, the chloride salts of common divalent cations (such as CaCl 2
FIG. 2. Protein stability surfaces. A subset of ThermoFluor
® -derived
T m values from the pH-salt profile plotted as a function of NaCl and pH, generating a stability surface for (A) cFMS and (B) Akt-3. Stability surfaces represent 9 buffers (acetate, pH 4 and 5; MES, pH 6 and 6.5, HEPES, pH 7, 7.5, and 8; borate, pH 8.5; each at 25 mM) and 7 [NaCl] (25, 50, 100, 200, 300, 400, and 500 mM).
or NiCl 2 ), as well as common detergents and additives (such as Tween and glycerol). Most salts again show dose-dependent stabilization of cFMS (Fig. 4C) and destabilization of Akt-3 (Fig.  4D) . Zinc showed a substantial dose-dependent destabilization of cFMS but has no effect on Akt-3. Calcium and nickel showed little effect on the stability of cFMS and Akt-3, yet these cations have significantly altered the stability of some affinity-tagged proteins (data not shown).
Optimizing protein purification. The initial purification procedures for cFMS and Akt-3 catalytic kinase domains were derived from either previously published protocols 25 or by using a standard kit-based protocol typically employed for purification of affinity-tagged proteins (details are available in the Materials and Methods section). Size-exclusion chromatography (SEC) and sodium dodecyl sulfate (SDS) polyacrylamide gels were used to gauge quality, purity, and tendency to aggregate protein preps following affinity chromatography. Initially, both proteins exhibited a strong tendency to aggregate and generally low purity (Fig.  5A, B) ; SEC revealed high-molecular-weight species eluting prior to the monomeric peaks. Moreover, SDS polyacrylamide gel electrophoresis indicated that the monomeric fractions of both cFMS and Akt-3 are not homogenous (< 90% purity) and were unsuitable for structural studies. The ThermoFluor ® -derived PSPs established for cFMS and Akt-3 provided information on conditions that could stabilize (or destabilize) these proteins. Stabilizing conditions were incorporated into protein purification protocols to limit aggregation, increase protein purity, and improve yield. For cFMS, stability was enhanced at high pH, high salt, and in phosphate buffer, whereas stability was decreased by Zn 2+ and imidazole (∆T m ∼ -1.2 at 100 mM; not shown). Based on these observations, new conditions for affinity chromatography were chosen. First, the buffer was changed from HEPES to NaPO 4 (each were pH 7.5) to exploit the stabilizing effect of phosphate on cFMS and to minimize the pH increase associated with HEPES buffer at low temperatures. Second, to reduce the potential negative impact of imidazole and divalent metal on protein aggregation and purity, the Ni-NTA resin was replaced with a cobalt-based TALON resin, which limits the amount of imidazole required to elute His6-cFMS (data not shown), consistent with the performance expectations of the TALON resin. 27 Following column elution, the imidazole was removed by immediate dialysis. Incorporating these changes in cFMS purification collectively reduced aggregation and significantly increased the purity (>98%) of the monomeric fraction when compared to the original purification (Fig. 5A vs 5C) . By a similar process, several changes were also made to the GST-Akt-3 purification, based on the ThermoFluor ® -derived PSP. The buffer used during purification was changed from Tris to PIPES, which has a smaller heat of buffer ionization relative to Tris 28 (minimizing the increase in pH at low temperatures, a destabilizing effect). The pH was decreased from 8.0 to 6.8, where Akt-3 showed better stability (Fig. 3B) . Based on the sensitivity of Akt-3 to [NaCl] the salt concentration was decreased from 150 to 100 mM during purification. Finally, 10% glycerol was added (a stabilizing effect, data not shown). As a result, Akt-3 aggregation was reduced, purity was increased (>98%), and yields improved compared to the original Akt-3 purification.
To demonstrate the performance benefits of aggregate free protein during in vitro stability assays, non-normalized ThermoFluor ® stability data are shown for cFMS and Akt-3 (Fig. 6) comparing data from initial and optimized protein purification procedures. One measure of the amount of (initially) native protein is the amplitude of ThermoFluor ® fluorescence intensity change between folded and unfolded forms, ∆y(T) = y U (T) -y F (T), the difference in absolute change in fluorescence between pretransition and posttransition baseline fluorescence. For cFMS (Fig. 6A) , unfolding transitions are shown for initial and optimized purification; the 4-fold difference in signal amplitude is readily apparent (∆y ∼3000 RFU for aggregate-prone protein compared with ∆y ∼11,000 RFU postoptimization). Likewise for Akt-3 (Fig. 6B) , the aggregateprone protein has a roughly 2-fold lower signal amplitude associated with unfolding (∆y ∼13,000 RFU initially compared with ∆y ∼30,000 RFU postoptimization). Although signal amplitude should be protein specific, equivalent data are expected comparing different preps of a single protein at a common concentration. Here, both proteins exhibited a significant loss of signal amplitude associated with the aggregate-prone preps, relative to protein from either optimized purification procedure, consistent with a larger fraction of soluble protein associated with optimized protein preps for both cFMS and Akt-3.
DISCUSSION
The relationship between aggregation and protein stability is a practical concern for a protein expression/purification needed for HTS, crystallography, drug discovery, and/or therapeutic protein production. Often, the same construct is used for more than 1 of the above functions and is supplied using the same protein expression/ purification resource. Aggregation is a problem that may become a critical bottleneck and is typically addressed by protein engineering through a combination of random and designed alterations in the expressed protein sequence. An alternative approach is to find conditions that stabilize existing protein constructs. Here, a ThermoFluor ® -derived PSP facilitated the transition of 2 targets into drug discovery programs, each of which had issues with both aggregation and purity.
In addition to the primary amino acid sequence and tertiary fold, protein stability and the tendency of proteins to aggregate are influenced by a number of factors. Ligand binding is well documented as a general effector of protein stability; for ligands that bind the native state, protein stability is increased in proportion to the affinity and concentration of ligand. 29 Solution composition has also been well established as influencing protein stability, either directly through binding or indirectly through solvent effects that differentially modulate the thermodynamics of the native and unfolded protein. 8 Finally, as the pH of a system is varied, the charged state of the protein will also vary, fundamentally changing the effect of solution composition on protein stability. 5 All of these can unpredictably influence protein stability and the propensity of a protein to aggregate.
Buffer ionization effects. One caveat associated with experiments designed to discriminate effects of solvent composition is the contribution of buffer ionization enthalpy (∆ ion H) and the resulting temperature-dependent pH. 28 Buffer solutions are commonly prepared at room temperature. Protein purification is routinely performed at 4 °C; thus, some modulation in pH as a function of temperature can be expected. The pH change associated with this temperature difference may unpredictably affect protein stability. Likewise, during the course of ThermoFluor ® experiments, protein solutions are heated well in excess of physiological temperatures, potentially changing the pH significantly. In our PSP, buffers of differing heats of ionization are used, and so a sense of a protein's sensitivity to temperature-mediated pH fluctuations can be discerned by cross-comparison of stability between buffers. cFMS is destabilized more by buffers known to acidify on heating and had decreased stability with increasing acidity (Fig. 4) . In contrast, Akt-3 is more stable in the acidic pH range. Buffers that acidify on heating (HEPES, Tris) were stabilizing for Akt-3, consistent with a temperature-induced solution acidification during the thermal increase in ThermoFluor ® experiments. The corollary increase in pH on cooling induces a decrease in stability, a relevant effect in selecting alternative conditions for purification at 4 °C. Further stability profiling on related and unrelated kinases may suggest common traits and/or differences that correlate among closely related kinases.
Plate-based protein characterization. Using an efficient highthroughput approach at condition profiling, we examined hundreds of conditions in parallel, quantitating the effects of buffer Aggregation resulted from initial purification protocols for cFMS and Akt-3. The initial cFMS construct possessed an Nterminal His-tag for nickel-NTA affinity column purification; impure material prone to aggregation was obtained (Fig. 5A) . Likewise, aggregation in initial Akt-3 purification was encountered, limiting in vitro functional studies. Significantly different PSPs led to resolution of these challenges. For HTS, structure-driven drug discovery, and generation for protein therapeutics-programs that require large quantities of pure protein-uncontrolled aggregation limits progress if found to be insurmountable. A comparison of ThermoFluor ® stability data for aggregate-prone protein with data for protein resulting from the revised purification procedures (Fig. 6) differentiates what was initially unusable protein before stability profiling and what surpassed quality thresholds for use in HTS and subsequent binding studies.
Mechanistically, solution-dependent effects on cFMS and Akt-3 unfolding are undoubtedly heterogeneous in origin. 5, 6, 8 These include direct binding of solutes to protein, indirect solute effects mediated through changes in water activity, and titration of ionizable groups from changing pH, any of which may stabilize or destabilize the native state, the unfolded state, or the transition state, in some unpredictable combination. The resulting solutiondependent stability changes may arise from direct binding to stabilize the native protein or affect aggregation rate, from a change in water activity, or perhaps may effect reversibility of unfolding. Additional biophysical experiments (eg, olute binding studies, linkage of protonation to stability, and kinetic analysis of folding and unfolding rates) would be warranted to further characterize individual mechanistic effects on protein stability.
Although the particular solution conditions or protein impurities present that originally favored aggregation for both cFMS and Akt-3 are likely pluralistic in origin, they were serendipitously eliminated through condition sampling in our stability profiling that translated to improved purification protocols for both proteins. The protein stability profiles indicate which conditions may be exploited (those additives that are stabilizing) or more importantly, which conditions should potentially be avoided (destabilizing buffer components) in circumventing problematic aggregation. The same matrix-based profiling approach is currently being extended to target activity analysis, and a comparison of condition-specific effects on stability vs activity, and inhibition of activity, allow much greater understanding of protein biophysics relevant to elucidating compound mechanism of action.
A practical application could be envisioned as a logical extension of the concepts presented here. If each protein/ construct/mutant gave a unique stability response to a widely defined set of conditions, as was sparsely described for these 2 therapeutic receptor tyrosine kinases, then a PSP fingerprint could be defined experimentally that might be truly unique. A stability fingerprint could be used to optimize protein preparations, select crystallography solutions, design protein formulations, analyze batch reproducibility, or discriminate among protein variants, both natural (isozymes, posttranslational modifications, or single-nucleotide polymorphisms) and artificial (such as domain truncations or point mutations) in origin. Such a tool could significantly contribute to the quality control of commercial or therapeutic proteins.
